Morgan Stanley’s CNS Pharmaceuticals CNSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2
| Closed | -$3 | – | 7943 |
|
|
2024
Q2 | $3 | Sell |
2
-65
| -97% | -$98 | ﹤0.01% | 7823 |
|
|
2024
Q1 | $24 | Sell |
67
-67
| -50% | -$24 | ﹤0.01% | 7689 |
|
|
2023
Q4 | $170 | Buy |
134
+67
| +100% | +$85 | ﹤0.01% | 7365 |
|
|
2023
Q3 | $76 | Buy |
+67
| New | +$76 | ﹤0.01% | 7464 |
|
|
2022
Q1 | – | Sell |
-5,500
| Closed | -$4K | – | 7982 |
|
|
2021
Q4 | $4K | Sell |
5,500
-13
| -0.2% | -$9 | ﹤0.01% | 7680 |
|
|
2021
Q3 | $8K | Sell |
5,513
-6,987
| -56% | -$10.1K | ﹤0.01% | 7388 |
|
|
2021
Q2 | $25K | Hold |
12,500
| – | – | ﹤0.01% | 6925 |
|
|
2021
Q1 | $30K | Hold |
12,500
| – | – | ﹤0.01% | 6572 |
|
|
2020
Q4 | $22K | Hold |
12,500
| – | – | ﹤0.01% | 6402 |
|
|
2020
Q3 | $22K | Buy |
+12,500
| New | +$22K | ﹤0.01% | 6022 |
|
|
2020
Q2 | – | Sell |
-2,035
| Closed | -$4K | – | 6613 |
|
|
2020
Q1 | $4K | Buy |
2,035
+1,982
| +3,740% | +$3.9K | ﹤0.01% | 6265 |
|
|
2019
Q4 | $0 | Buy |
+53
| New | – | ﹤0.01% | 6658 |
|